
Innodata Inc.
NASDAQ•INOD
CEO: Mr. Jack S. Abuhoff J.D.
Sector: Technology
Industry: Information Technology Services
Listing Date: 1993-08-10
Innodata Inc. operates as a global data engineering company in the United States, the United Kingdom, the Netherlands, Canada, and internationally. The company operates through three segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment engages in the provision of artificial intelligence (AI) data preparation services; collecting or creating training data; annotating training data; and training AI algorithms for its customers, as well as AI model deployment and integration services. This segment also provides a range of data engineering support services, including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management. The Synodex segment offers an industry platform that transforms medical records into useable digital data with its proprietary data models or client data models. The Agility segment provides an industry platform that offers marketing communications and public relations professionals to target and distribute content to journalists and social media influencers; and to monitor and analyze global news channels, such as print, web, radio, and TV, as well as social media channels. It serves banking, insurance, financial services, technology, digital retailing, and information/media sectors through its professional staff, senior management, and direct sales personnel. The company was formerly known as Innodata Isogen, Inc. and changed its name to Innodata Inc. in June 2012. Innodata Inc. was incorporated in 1988 and is headquartered in Ridgefield Park, New Jersey.
Contact Information
55 Challenger Road, Suite 202, Ridgefield Park, NJ, 07660, United States
201-371-8000
Market Cap
$1.67B
P/E (TTM)
49.7
20.3
Dividend Yield
--
52W High
$93.85
52W Low
$26.41
52W Range
Rank54Top 66.0%
3.1
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Weak • 3.1 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024
Financial Dashboard
Q3 2025 Data
Revenue
$62.55M+19.77%
4-Quarter Trend
EPS
$0.26-56.67%
4-Quarter Trend
FCF
$14.54M+46.64%
4-Quarter Trend
2025 Q3 Earnings Highlights
Key Highlights
Nine-Month Revenue Surge Total revenues reached $179.3M, marking a 61% increase over prior period, driven by DDS segment growth.
Net Income Improvement Attributable net income grew to $23.3M for nine months, reflecting improved profitability across core segments.
Strong Operating Cash Flow Cash provided by operating activities totaled $33.9M for nine months, nearly doubling prior period results.
DDS Segment Dominance DDS segment revenue grew 74% to $156.2M for nine months, supporting overall company expansion efforts.
Risk Factors
DDS Customer Concentration One DDS customer accounted for 58% of nine-month revenues, posing significant revenue dependency risk.
Securities Class Action Risk Pending Securities Class Action litigation outcome is uncertain; potential adverse financial impact cannot be assured.
Philippine Judgment Exposure Active litigation involves potential $5.6M judgment plus accrued interest from inactive Philippine subsidiary.
Synodex Margin Decline Synodex gross margin fell to 19% (9M 2025) due to lower revenues and higher direct operating costs.
Outlook
Liquidity Position Solid Cash and equivalents stand at $73.9M; management expects sufficient liquidity for at least next 12 months.
Capital Expenditure Planning Anticipated capital expenditures for next 12 months approximate $11.0M, focused on software and infrastructure upgrades.
AI Platform Development Developing additional AI-enabled industry platform for financial services institutions based on core competencies.
Tax Legislation Evaluation Management continues evaluating potential impact of recent OBBBA legislation on deferred tax assets and rate.
Peer Comparison
Revenue (TTM)
DXC$12.71B
CNXC$9.72B
$3.99B
Gross Margin (Latest Quarter)
CLVT65.0%
57.5%
43.7%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| VICR | $5.00B | 60.4 | 13.8% | 1.0% |
| GLOB | $2.97B | 30.1 | 4.8% | 14.2% |
| DXC | $2.72B | 7.2 | 12.0% | 34.6% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
1.9%
Moderate Growth
4Q Net Income CAGR
-6.8%
Declining Profitability
Cash Flow Stability
100%
Strong Cash Flow
Research & Insights
Next earnings:Feb 19, 2026
EPS:$0.22
|Revenue:-
Reports
All Years
Form 10-Q - Q3 2025
Period End: Sep 30, 2025|Filed: Nov 6, 2025|Revenue: $62.55M+19.8%|EPS: $0.26-56.7%BeatForm 10-Q - Q2 2025
Period End: Jun 30, 2025|Filed: Jul 31, 2025|Revenue: $58.39M+79.4%|EPS: $0.23-46100.0%BeatForm 10-Q - Q1 2025
Period End: Mar 31, 2025|Filed: May 9, 2025|Revenue: $58.34M+120.1%|EPS: $0.25+733.3%BeatForm 10-K - FY 2024
Period End: Dec 31, 2024|Filed: Feb 24, 2025|Revenue: $170.46M+96.4%|EPS: $0.98+3366.7%BeatForm 10-Q - Q3 2024
Period End: Sep 30, 2024|Filed: Nov 7, 2024|Revenue: $52.22M+135.6%|EPS: $0.60+5900.0%BeatForm 10-Q - Q2 2024
Period End: Jun 30, 2024|Filed: Aug 9, 2024|Revenue: $32.55M+65.6%|EPS: $-0.00-98.3%BeatForm 10-Q - Q1 2024
Period End: Mar 31, 2024|Filed: May 8, 2024|Revenue: $26.50M+40.7%|EPS: $0.03-137.5%MissForm 10-K - FY 2023
Period End: Dec 31, 2023|Filed: Mar 4, 2024|Revenue: $86.78M+9.8%|EPS: $-0.03+93.2%Miss